Accuracy Compared

NIPT vs Double Marker Test — An Honest Comparison

The double marker (free β-hCG + PAPP-A) and NIPT both screen for Down syndrome in the first trimester — but they differ substantially in accuracy. Here is the comparison that matters.

NMC Registered100% ConfidentialAccredited LabHome Collection

Detection accuracy — the decisive difference

NIPT detects over 99% of Down syndrome pregnancies; the double marker (combined with NT ultrasound) detects roughly 85–90%. False positives tell the bigger story: NIPT produces them in under 0.1% of low-risk pregnancies, while serum screening flags ~5% — meaning fifty times fewer women face unnecessary invasive testing after NIPT.

What each test measures

The double marker measures maternal serum proteins (free β-hCG and PAPP-A) whose levels shift statistically in trisomy pregnancies — an indirect proxy. NIPT measures the fetal DNA itself — the actual chromosomal material — which is why it is so much more accurate.

Timing and cost

The double marker runs at 11–13+6 weeks and costs significantly less. NIPT is valid from 10 weeks onward (any trimester) and costs more — but its accuracy prevents the cascade of anxiety, repeat testing, and invasive procedures that false positives cause.

A common practical pathway in Nepal: double marker plus NT scan as the first level, with NIPT for high-risk results or for those wanting maximal accuracy directly.

What the double marker still adds

The combined first-trimester screen includes the NT ultrasound — an early anatomy check that detects major structural problems NIPT cannot see. The tests answer different questions; the serum portion's accuracy is simply no match for NIPT's.

Frequently Asked Questions

Should I skip the double marker and just do NIPT?
Many patients do exactly that — NIPT is the superior screen. Keep the NT ultrasound for anatomy assessment regardless.
My double marker is high risk — what now?
NIPT is the natural intermediate step before invasive testing — most high-risk serum screens resolve to low-risk on NIPT, sparing amniocentesis.
Is the double marker ever enough?
For lower-risk patients comfortable with ~90% detection it remains a valid, economical screen — but know its limits compared to NIPT.

Book Your Confidential Test

Walk-in, home, or hotel sample collection in Kathmandu. Accredited laboratory processing with fully confidential reporting.

WhatsAppBook Now